ClinicalTrials.gg
Active, not recruitingNCT07753707Updated Nov 12, 2026

Influence of the Different Types of Tibial Fixation in the Reconstruction of the Anterior Cruciate Ligament of the Knee: Osseous Integration, Ligament Maturation and Clinical Results.

An interventional study of Anterior cruciate ligament (ACL) reconstruction in ACL - Anterior Cruciate Ligament Rupture, sponsored by Institut Català de Traumatologia i Medicina de l'Esport. Active, not recruiting at 1 site in Spain. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by Institut Català de Traumatologia i Medicina de l'Esport · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 3 years after the study started (first participant enrolled Sep 2022, registered Sep 2025).
Updated Nov 12, 2026Start date movedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
111
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 12 studies in Anterior Cruciate Ligament Injuries with a site in Spain — 6 open to participants now, 7 under way, none of them phase 3. Anterior Cruciate Ligament Injuries · Spain.

Planned enrollment
Largest of 10
111 · median 44
Started
2022
with 1 other
No phase
10 of 12
4 open now
Registered
10th of 12
by date
Lead sponsor
1 of 12
Institut Català de Traumatologia i Medicina de l'Esport

Among the 12 studies in Anterior Cruciate Ligament Injuries with a site in Spain, this one has the largest planned enrollment of the 10 interventional ones that give a count, is one of 2 that started in 2022, is one of 10 with no phase, and was the 10th registered.

Anterior Cruciate Ligament Injuries

627 studies on the registry are indexed under Anterior Cruciate Ligament Injuries; 193 are open to participants now.

Browse Anterior Cruciate Ligament Injuries studies →

Open to participants now

6 of the 12 studies in Anterior Cruciate Ligament Injuries with a site in Spain are open now. Recruiting first, the newest first:

1 more — sign in →

All 6 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 122 Anterior Cruciate Ligament Injuries studies recruiting now, 27 (22%) set no upper age limit and 92 (75%) stop at 75 or younger; 46 take children under 18; 21 take healthy volunteers.

This study: 18 Years to 50 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Anterior Cruciate Ligament Injuries with a site in Spain, or all of them as a file.
02

Study summary

Influence of different tibial fixation methods in anterior cruciate ligament (ACL) reconstruction: bone integration, graft maturation, and clinical outcomes.

Primary Objective

To assess whether any of the three tibial fixation techniques is superior in terms of:

  • Graft-bone integration (CT/MRI).
  • Graft maturation (MRI, signal-to-noise quotient at 12 months).
  • Clinical outcomes (IKDC, Lysholm and Tegner scores; manual and instrumented knee stability with the Lachman and pivot-shift tests and the KT-1000 arthrometer).

Secondary Objectives

  • Compare clinical outcomes among groups (IKDC, Lysholm, Tegner).
  • Compare complication and re-rupture rates and patient satisfaction among groups.

Study Design Prospective, single-center, three-arm randomized controlled trial.

Inclusion Criteria

  • Age 18 to 50 years.
  • Primary complete ACL tear with indication for arthroscopic reconstruction with hamstring autograft.

Exclusion Criteria

  • Revision ACL surgery.
  • Use of a graft other than hamstring tendons.
  • Kellgren-Lawrence grade III-IV osteoarthritis.
  • Inflammatory knee disease. Note: soft tissue procedures (e.g., meniscal repair) are not exclusion criteria.

Randomization

Patients meeting the inclusion and exclusion criteria are randomized (Research Randomizer, https://www.randomizer.org/) into 3 groups:

  • Group A (TORN): bioabsorbable interference screw, same diameter as the tunnel.
  • Group B (TORN+1): bioabsorbable interference screw, 1 mm larger than the tunnel diameter.
  • Group C (TORN-BT): interference screw (same diameter as the tunnel) plus second fixation with a cortical button.

Sample size: 37 patients per group, 111 in total.

Follow-up

  • Preoperative radiographic evaluation.
  • CT at 15 days and at 12 months postoperatively.
  • MRI at 12 months postoperatively.
  • Clinical follow-up at 2 years postoperatively.

Statistical Analysis Pre- and postoperative variables will be compared within groups, and all variables will be compared between groups using parametric or non-parametric tests according to data distribution (Student's t-test or ANOVA, or their non-parametric equivalents). Linear regression models will be applied to test for potential significance that could be masked by confounding factors.

03

Conditions studied

  • ACL - Anterior Cruciate Ligament Rupture
04

Who can participate

The criteria were revised on the registry on Nov 12, 2026. See what changed

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 to 50 years.
  • Primary complete ACL tear with indication for arthroscopic reconstruction with hamstring autograft.

Exclusion criteria

Exclusion Criteria

  • Revision ACL surgery.
  • Use of a graft other than hamstring tendons.
  • Kellgren-Lawrence grade III-IV osteoarthritis.
  • Inflammatory knee disease. Note: soft tissue procedures (e.g., meniscal repair) are not exclusion criteria.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
111 participants (estimated)

Study arms

  • Active comparator
    Group A (TORN): tibial graft fixation bioabsorbable interference screw, same diameter as the tunnel.

    Procedure: Anterior cruciate ligament (ACL) reconstruction

  • Active comparator
    Group B (TORN+1): bioabsorbable interference screw, one mm larger than the tunnel diameter.

    Procedure: Anterior cruciate ligament (ACL) reconstruction

  • Active comparator
    Group C (TORN-BT): interference screw (same size as tunnel) + second fixation with cortical button

    Procedure: Anterior cruciate ligament (ACL) reconstruction

Interventions

  • ProcedureAnterior cruciate ligament (ACL) reconstruction

    The three different types of tibial fixation in ACL reconstruction with Hamstring autograft: Group A (TORN): bioabsorbable interference screw, same diameter as the tunnel. Group B (TORN+1): bioabsorbable interference screw, one mm larger than the tunnel diameter. Group C (TORN-BT): interference screw (same size as tunnel) + second fixation with cortical button/plate.

06

What researchers measure

Primary outcomes

  1. ACL Graft-bone integration (CT/MRI)

    Graft-bone integration assessed by CT or MRI according to tunnel healing and bone incorporation.

    Time frame: 12 months

  2. Graft maturation (MRI)

    Graft maturation assessed on MRI using the Signal-to-Noise Quotient (SNQ).

    Time frame: 12 months

Secondary outcomes

  1. International Knee Documentation Committee (IKDC) Subjective Knee Evaluation Score

    Patient-reported knee function. Scores range from 0 to 100, with higher scores indicating better knee function.

    Time frame: 24 months

  2. Tegner Activity Scale

    Activity level assessed using the Tegner Activity Scale. Scores range from 0 to 10, with higher scores indicating higher activity levels.

    Time frame: 24 months

  3. Side-to-side anterior knee laxity measured with KT-1000 arthrometer

    Anterior tibial translation measured using a KT-1000 arthrometer. Lower side-to-side differences indicate better knee stability.

    Time frame: 24 months

07

Study locations

1 site
08

References and documents

Publications

  • Mathew M, Dhollander A, Getgood A. Anterolateral Ligament Reconstruction or Extra-Articular Tenodesis: Why and When? Clin Sports Med. 2018 Jan;37(1):75-86. doi: 10.1016/j.csm.2017.07.011. Epub 2017 Oct 3. PubMed 29173559 ↗
  • Granan LP, Bahr R, Steindal K, Furnes O, Engebretsen L. Development of a national cruciate ligament surgery registry: the Norwegian National Knee Ligament Registry. Am J Sports Med. 2008 Feb;36(2):308-15. doi: 10.1177/0363546507308939. Epub 2007 Nov 7. PubMed 17989167 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2022 to primary completion in Oct 2025, 37 months.

Of 279 non-industry interventional studies with no phase under Anterior Cruciate Ligament Injuries, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 70. This study's 37 months is above that.

Counting every sponsor, half of 288 studies reached it within 30 months; a quarter within 14 and three quarters within 70.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 12, 2026: start Jan 2023 → Sep 2022 and primary completion Jan 2026 → Oct 2025.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 30, 2025
First posted
Aug 7, 2026
StartActual
Sep 7, 2022was Jan 2023
Primary completionActual
Oct 31, 2025was Jan 2026
CompletionEst.
Dec 30, 2026
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Jan 7, 2023→Sep 7, 2022
Nov 12, 2026
Primary completion
Jan 31, 2026→Oct 31, 2025
Nov 12, 2026
Eligibility
Maximum age 55 Years→50 Years; 2 inclusion criteria edited; 2 exclusion criteria edited, 2 added, 5 removed
What changed in the criteria
Inclusion criteria
  • EditedAge ≥18 to 50 years.
  • EditedCompletePrimary complete ACL rupture treatedtear with indication for arthroscopic ACL reconstruction using autologouswith hamstring tendonsautograft.
Exclusion criteria
  • RemovedAge ≥55 years.
  • RemovedPatients treated with allografts, bone-patellar tendon-bone grafts, or quadriceps tendon grafts.
  • RemovedMalpositioned tunnels (evaluated by MRI at 6 months postop).
  • EditedPrevious kneeRevision ACL surgery.
  • RemovedFemoral or tibial deformities.
  • RemovedMultiligament injuries.
  • AddedUse of a graft other than hamstring tendons.
  • AddedKellgren-Lawrence grade III-IV osteoarthritis.
  • EditedInflammatory knee disease. Note: Softsoft tissue procedures (e.g., meniscal repair) are not exclusion criteria.
Nov 12, 2026
Primary outcomes
1 time frame changed
What changed in the outcomes
  • Time frameGraft maturation (MRI)6-12 months → 12 months
Nov 12, 2026
Secondary outcomes
3 time frame changed
What changed in the outcomes
  • Time frameInternational Knee Documentation Committee (IKDC) Subjective Knee Evaluation Score12 months → 24 months
  • Time frameTegner Activity Scale12 months → 24 months
  • Time frameSide-to-side anterior knee laxity measured with KT-1000 arthrometer12 months → 24 months
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    Start date Jan 7, 2023→Sep 7, 2022
    Primary completion Jan 31, 2026→Oct 31, 2025
    Eligibility Maximum age 55 Years→50 Years; 2 inclusion criteria edited; 2 exclusion criteria edited, 2 added, 5 removed
    What changed in the criteria
    Inclusion criteria
    • EditedAge ≥18 to 50 years.
    • EditedCompletePrimary complete ACL rupture treatedtear with indication for arthroscopic ACL reconstruction using autologouswith hamstring tendonsautograft.
    Exclusion criteria
    • RemovedAge ≥55 years.
    • RemovedPatients treated with allografts, bone-patellar tendon-bone grafts, or quadriceps tendon grafts.
    • RemovedMalpositioned tunnels (evaluated by MRI at 6 months postop).
    • EditedPrevious kneeRevision ACL surgery.
    • RemovedFemoral or tibial deformities.
    • RemovedMultiligament injuries.
    • AddedUse of a graft other than hamstring tendons.
    • AddedKellgren-Lawrence grade III-IV osteoarthritis.
    • EditedInflammatory knee disease. Note: Softsoft tissue procedures (e.g., meniscal repair) are not exclusion criteria.
    Primary outcomes 1 time frame changed
    What changed in the outcomes
    • Time frameGraft maturation (MRI)6-12 months → 12 months
    Secondary outcomes 3 time frame changed
    What changed in the outcomes
    • Time frameInternational Knee Documentation Committee (IKDC) Subjective Knee Evaluation Score12 months → 24 months
    • Time frameTegner Activity Scale12 months → 24 months
    • Time frameSide-to-side anterior knee laxity measured with KT-1000 arthrometer12 months → 24 months
    + 2 other changes: verification date and description

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07753707
Lead sponsor
Institut Català de Traumatologia i Medicina de l'Esport
Responsible party
Sponsor
First posted
Aug 7, 2026
Start date
Sep 7, 2022
Primary completion
Oct 31, 2025
Completion
Dec 30, 2026 (estimated)
Last update
Nov 12, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion